These findings are in agreement with Miquilena-Colina et al. who observed a significant correlation between hepatic CD36 expression and plasma insulin levels and insulin resistance (HOMA-IR) in patients with NASH [28]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.